Clinical Trial Update: A Bioequivalence Study Comparing Camoquin® Suspension (Pfizer) To Flavoquine® Tablets (Sanofi Aventis) In Healthy Subjects [Phase 4]

View source ↗

Summary

A Phase 4 bioequivalence trial compared Camoquin Suspension (Pfizer) to Flavoquine Tablets (Sanofi Aventis) in healthy subjects; the study assessing Falciparum …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria Falciparum

Drugs mentioned

• Camoquin Suspension
• Flavoquine Tablets

Snippet

Sponsor: Pfizer | Conditions: Falciparum Malaria | Phase 4 | Status: COMPLETED